Literature DB >> 16819118

Introduction of pneumococcal conjugate vaccine into the Dutch national immunisation programme.

M van Oosten1, S C de Greeff, L Spanjaard, L M Schouls.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16819118     DOI: 10.2807/esw.11.23.02968-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


× No keyword cloud information.
  4 in total

1.  Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands.

Authors:  Gerwin D Rodenburg; Sabine C de Greeff; Angelique G C S Jansen; Hester E de Melker; Leo M Schouls; Eelko Hak; Lodewijk Spanjaard; Elisabeth A M Sanders; Arie van der Ende
Journal:  Emerg Infect Dis       Date:  2010-05       Impact factor: 6.883

2.  Effect of seven-valent pneumococcal conjugate vaccine on Staphylococcus aureus colonisation in a randomised controlled trial.

Authors:  Elske J M van Gils; Eelko Hak; Reinier H Veenhoven; Gerwin D Rodenburg; Debby Bogaert; Jacob P Bruin; Loek van Alphen; Elisabeth A M Sanders
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

3.  Neutral and acidic oligosaccharides supplementation does not increase the vaccine antibody response in preterm infants in a randomized clinical trial.

Authors:  Jolice P van den Berg; Elisabeth A M Westerbeek; Fiona R M van der Klis; Guy A M Berbers; Harrie N Lafeber; Ruurd M van Elburg
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

4.  Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands.

Authors:  Anna M M van Deursen; Suzan P van Mens; Elisabeth A M Sanders; Bart J M Vlaminckx; Hester E de Melker; Leo M Schouls; Sabine C de Greeff; Arie van der Ende
Journal:  Emerg Infect Dis       Date:  2012-11       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.